Yu-Waye Chu

Track

Insider profile

Currently holds a position at Fate Therapeutics Inc

Performance

Overall performance
4.0
Performance over holding periods
4.0
30 days 90 days 120 days
Average return 18% 8.2% 15.1%
Success rate 95% 68% 82%
Transactions
11 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Vice President - Clinical Devel Fate Therapeutics Inc April 18, 2019 -
Yu-Waye Chu's trades of CytomX Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
6.58
Quantity 2,532
Value US$16,654
Transaction date
Planned sale
Price
49.32
Quantity 2,097 -1.6%
Value US$103,424
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-19 2026-03-17
S Sale
4,844 +25.3%
150.04
US$2,742,864 		4,844 +25.3% 150.04 US$2,742,864
2025-03-20 2025-03-18
S Sale
69,820 -27.0%
256.37
US$4,192,009 		69,820 -27.0% 256.37 US$4,192,009
2023-04-19 2023-04-18
S Sale
62,496 -11.5%
203.10
US$300,321 		62,496 -11.5% 203.10 US$300,321
2023-04-19 2023-04-18
S Sale
215 -0.2%
6.52
US$1,402 		215 -0.2% 6.52 US$1,402
2023-04-18 2023-04-18
PrS Proposed sale
2,532
6.58
US$16,654 		2,532 6.58 US$16,654
2023-01-11 2023-01-10
S Sale
7,825 -5.2%
5.24
US$41,003 		7,825 -5.2% 5.24 US$41,003
2022-04-21 2022-04-19
S Sale
4,062 -2.6%
35.37
US$143,673 		4,062 -2.6% 35.37 US$143,673
2022-01-13 2022-01-11
S Sale
418 -0.3%
49.10
US$20,524 		418 -0.3% 49.10 US$20,524
2022-01-13 2022-01-11
S Sale
3,547 -2.8%
48.44
US$171,817 		3,547 -2.8% 48.44 US$171,817
2021-12-13 2021-12-10
PlS Planned sale
5 -0.0%
55.54
US$278 		5 -0.0% 55.54 US$278
2021-12-13 2021-12-10
PlS Planned sale
600 -0.5%
54.58
US$32,748 		600 -0.5% 54.58 US$32,748
2021-12-13 2021-12-10
PlS Planned sale
1,031 -0.8%
53.66
US$55,323 		1,031 -0.8% 53.66 US$55,323
2021-12-13 2021-12-10
PlS Planned sale
1,822 -1.4%
52.37
US$95,418 		1,822 -1.4% 52.37 US$95,418
2021-12-13 2021-12-10
PlS Planned sale
1,045 -0.8%
51.08
US$53,379 		1,045 -0.8% 51.08 US$53,379
2021-12-13 2021-12-10
PlS Planned sale
900 -0.7%
50.42
US$45,378 		900 -0.7% 50.42 US$45,378
2021-12-13 2021-12-10
PlS Planned sale
2,097 -1.6%
49.32
US$103,424 		2,097 -1.6% 49.32 US$103,424
2021-04-20 2021-04-16
S Sale
1,500 -2.3%
84.41
US$126,615 		1,500 -2.3% 84.41 US$126,615
2021-04-20 2021-04-16
S Sale
900 -1.3%
82.91
US$74,619 		900 -1.3% 82.91 US$74,619
2021-04-20 2021-04-16
S Sale
875 -1.3%
81.80
US$71,575 		875 -1.3% 81.80 US$71,575